Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus

Judith K. Wolf, Tae Eung Kim, Diane Fightmaster, Diane Bodurka, David M. Gershenson, Gordon Mills, J. Taylor Wharton

    Research output: Contribution to journalArticle

    31 Scopus citations

    Abstract

    Objective. The cell cycle regulatory protein p16 (CDKN2/cyclin dependent kinase 4 inhibitor/multiple tumor suppressor-1) causes cell cycle arrest at the G1 checkpoint by inhibiting activity of cyclin D-CDK4 complexes. The purpose of this study is to assess the effect of introduction of the p16 gene into two ovarian cancer cell lines via a recombinant adenoviral vector (Ad5CMV-p16). Methods. Cells lines used were SKOV3, which has a p16 deletion, and OVCA420, which has normal p16. Transduction efficiency was established by infecting cells with an adenovirus containing the Escherichia coli β-galactosidase gene (Ad5CMV-β-gal) at multiplicity of infection from 0 to 1000 and staining for X-gal. Cells were infected with Ad5CMV-p16 and cell growth was assessed by counting cells every other day for up to 7 days. Western blotting was done to assess for p16 expression after infection. Fluorescence-activated cell sorting after staining with propidium iodide was done to assess the effect of p16 on the cell cycle. Results. The SKOV3 cell line was transduced with the adenovirus at a slightly lower MOI than the OVCA420 cell line. Growth of the Ad5CMV-p16-infected cells was suppressed 75- 80% by cell count in both cell lines and caused morphologic changes of the cells consistent with apoptosis. The p16 protein expression was seen to increase within 24 h after introduction of the p16 gene. G1 arrest of cells occurred beginning 24 h after introduction of the p16 gene. Conclusions. These results suggest that Ad5CMV-p16 may be further studied as a potential therapeutic agent for ovarian cancer as introduction of the p16 gene into ovarian cancer cell lines causes a G1 arrest and attenuation of growth, regardless of the endogenous p16 status of the cells.

    Original languageEnglish (US)
    Pages (from-to)27-34
    Number of pages8
    JournalGynecologic oncology
    Volume73
    Issue number1
    DOIs
    StatePublished - Apr 1999

    ASJC Scopus subject areas

    • Oncology
    • Obstetrics and Gynecology

    Fingerprint Dive into the research topics of 'Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus'. Together they form a unique fingerprint.

  • Cite this